MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

Clinical trial NCT05409989 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05409989
Sponsor: Microvention-Terumo, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Intracranial Aneurysm

Start date: 2022-09-20
Primary completion: 2026-04-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.